Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dissolving stent could revolutionize treatment for long heart blockages

NCT ID NCT07091682

First seen Nov 21, 2025 · Last updated Jun 18, 2026 · Updated 24 times

Summary

This study tests a new type of heart stent made from magnesium that slowly dissolves over time. It is designed for people with long blockages in their heart arteries. The goal is to see if the stent is safe and works well at keeping arteries open for up to 12 months. About 100 participants with coronary artery disease will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Azienda Ospedaliera Universitaria Integrata Verona

    NOT_YET_RECRUITING

    Verona, 37126, Italy

    Contact

  • Centro Cardiologico Monzino SpA

    RECRUITING

    Milan, 20138, Italy

    Contact

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

    Contact

  • Katholisches Krankenhaus "St. Johann Nepomuk"

    RECRUITING

    Erfurt, 99097, Germany

    Contact

  • Klinikverbund Allgäu gGmbH

    RECRUITING

    Immenstadt and Kempten, 87509, Germany

    Contact

  • Miedziowe Centrum Zdrowia S.A

    RECRUITING

    Lubin, 59-311, Poland

    Contact

  • Pauls Stradins Clinical University Hospital

    RECRUITING

    Riga, 1002, Latvia

    Contact

  • Universitätsklinikum Halle (Saale)

    RECRUITING

    Halle, 6120, Germany

    Contact

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Angina Pectoris coronary artery disorder coronary atherosclerosis intermediate coronary syndrome myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.